Exfoliative dermatitis - I-Exfoliative Dermatitis
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Red (burning) Skin Syndrome ― Erythema kanye nesikali emzimbeni wonke izimpawu eziyinhloko ze-I-Exfoliative Dermatitis (Exfoliative dermatitis).
References
Erythroderma yisimo sesikhumba esingandile kodwa esibucayi. Nakuba imbangela eqondile ngokuvamile ingaziwa, ingabangelwa ukusabela kwezidakamizwa noma umdlavuza oyisisekelo. Umdlavuza owodwa ojwayelekile oxhunyaniswe ne-exfoliative dermatitis i-T-cell lymphoma ye-cutaneous, engase ingabonisi zimpawu izinyanga noma ngisho neminyaka ngemva kokuba isimo sesikhumba siqale. Ngokuvamile, ukulaliswa esibhedlela kuyadingeka ukuze kuhlolwe futhi ukwelashwa kokuqala. Iziguli ezinesifo esibangelwa izidakamizwa ngokuvamile ziba nombono omuhle wesikhathi eside, nakuba izimo ezingenaso isizathu esicacile zivame ukuba nenkambo ephindaphindayo nebuyisela emuva. Ukubikezelwa kwamacala ahlobene nomdlavuza ngokuvamile kuncike ekutheni umdlavuza uqhubeka kanjani.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Ngokujwayelekile ikhombisa ububomvu obusabalele kanye nokucwayiza okumboza ngaphezu kuka-90% womzimba. Lesi simo siwuphawu olubonakalayo lwezinkinga zempilo eziyisisekelo ezifana ne-psoriasis, i-eczema, noma impendulo emithini ethile.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Isizathu esivame kakhulu se-erythroderma ukubhebhetheka kwesifo sesikhumba esingaphansi, njenge-psoriasis, i-contact dermatitis, i-seborrheic dermatitis, i-lichen planus, i-pityriasis rubra pilaris noma ukusabela kwezidakamizwa, njengokusetshenziswa kwe-topical steroids. I-manefestation eyinhloko ayivamisile futhi ngokuvamile ibonakala ezimeni ze-T-cell lymphoma ye-cutaneous. Ngenxa yokuthi kubalulekile ukuyihlukanisa ne-cutaneous T cell lymphoma, i-biopsy iyenziwa.